Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy Based on Tumor Subtypes in Patients With Early-stage Breast Cancer: A Multi-institutional Retrospective Cohort Study

NCT06299930 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT06299930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06299930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy Based on Tumor Subtypes in Patients With Early-stage Breast Cancer: A Multi-institutional Retrospective Cohort Study
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Completed
Start date
April 22, 2022
Completion date
September 12, 2023
Enrollment
10,328 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer